Original Research
Published on 04 Nov 2025
Metabolic subtyping reveals PDIK1L as a dual-functional regulator of progression and PARP inhibitor sensitivity in prostate cancer
in Cancer Cell Biology
- 359 views
Original Research
Published on 04 Nov 2025
in Cancer Cell Biology
Original Research
Published on 04 Nov 2025
in Orthopedic Surgery
Original Research
Published on 04 Nov 2025
in Nephrology
Original Research
Published on 04 Nov 2025
in Psychology for Clinical Settings
Editorial
Published on 04 Nov 2025
in Antibiotic Resistance and New Antimicrobial drugs
Review
Published on 04 Nov 2025
in Clinical Nutrition
Editorial
Published on 04 Nov 2025
in Social Inclusion in Cities
Case Report
Published on 04 Nov 2025
in Hepatobiliary Diseases
Technology and Code
Published on 04 Nov 2025
in Neurogenomics
Original Research
Published on 04 Nov 2025
in Precision Medicine
Mini Review
Published on 04 Nov 2025
in Cytokines and Soluble Mediators in Immunity
Systematic Review
Published on 04 Nov 2025
in Cancer Immunity and Immunotherapy
Opinion
Published on 04 Nov 2025
in Public Health and Nutrition
Correction
Published on 04 Nov 2025
in Quality of Life
Case Report
Published on 04 Nov 2025
in Neuropharmacology
Original Research
Published on 04 Nov 2025
in Health Economics